Answers are grounded in this paper and cite their sources.
The Chromosomal Passenger Complex (CPC) is a key regulator of cell division. It comprises three structural proteins (Survivin, Borealin, and INCENP) and one enzymatic component (Aurora kinase B). CPC function depends on its localization, which is tightly regulated during mitosis in healthy cells. Many cancer types overexpress CPC components, which have been detected in both the nucleus and the cytoplasm. Recently, it was discovered that one CPC subunit, Survivin, is also displayed on the plasma membrane of tumor cells. This finding fueled interest in Survivin as a novel “Inside-Out” tumor target. Here, we used a comprehensive panel of synthetic antibodies to demonstrate that all four CPC members are presented on the surface of a wide range of tumor cells but are absent from healthy cells. Analysis of antibody binding indicated that they are attached to the membrane surface in specific orientations. We used electron microscopy and X-ray crystallography to further elucidate the structural basis of antibody binding to CPC components. In addition, a bispecific T-cell engager targeting a surface-exposed epitope of Survivin showed anti-tumor activity both in vitro and in vivo in a xenograft mouse model. The cancer-driven surface presentation of these proteins on the cell membrane, combined with their effectiveness as immunotherapeutic targets, underscores their potential as a new class of tumor-selective biomarkers.
No takes yet. Share an insight, caveat, or question.
Sääf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: